Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene

We have shown that individuals known to have diabetes caused by a mutation in the HNF1A gene have an increased risk of cardiovascular mortality compared with their unaffected family members. As with other forms of diabetes, consideration should be given to early statin therapy despite a seemingly protective lipid profile.